Edaravone shows promise in targeting brain tumor stem cells

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.

Philips IntelliSite Pathology Solution Receives 510(k) Clearance

What You Should Know: – Philips IntelliSite Pathology 5.1 has received 510(k) clearance from the FDA, solidifying its position as the most widely deployed digital

July 12, 2024

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research

August 28, 2023

After a Neuro Disorder Stole Her Voice, Rep. Jennifer Wexton Takes It Back

When Rep. Jennifer Wexton (D-Va.) rises Thursday to speak on the House floor, something she has done countless times before, she will be using a

July 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.